Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors

Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives Discovery of Novel c-Mesenchymal-Epithelia transition factor and histone deacetylase dual inhibitors Design, synthesis and evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold Efficient Synthesis and Bioevaluation of Novel Dual Tubulin/Histone Deacetylase 3 Inhibitors as Potential Anticancer Agents Design, synthesis and biological evaluation of novel histone deacetylase1/2 (HDAC1/2) and cyclin-dependent Kinase2 (CDK2) dual inhibitors against malignant cancer Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC–EGFR dual inhibitors Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery